Scientists have created a new test for identifying people at risk of developing acute myeloid leukemia and related cancers, years before they do. The new platform, "MN-predict," will allow doctors and scientists to identify ...
Aug 24, 2023
0
34
Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, according to a study published ...
Aug 17, 2023
0
29
The hepatic immune landscape is a dynamic compartment, notably composed of highly heterogeneous and adapting myeloid cells. Liver resident macrophage distribution across the tissue and bone-marrow derived monocyte accumulation ...
Aug 8, 2023
0
11
For patients with acute myeloid leukemia (AML), higher spleen volume at the time of hematopoietic stem cell transplant (HSCT) is associated with inferior overall survival and an increased incidence of nonrelapse mortality ...
Jul 19, 2023
0
0
McMaster researchers have uncovered a fast and effective way to detect cancer stem cells before the disease recurs in adults who previously underwent treatment.
Jul 17, 2023
0
39
Published in the Journal of Clinical Oncology, University of Minnesota Medical School researchers led a study that demonstrated the safety of using microbiota transplant therapy (MTT) in patients with acute myeloid leukemia ...
Jul 6, 2023
0
5
A new editorial paper titled "Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability" has been published in Oncotarget.
Jun 28, 2023
0
2
Patients with a rare genetic bone marrow disorder that puts them at increased risk of blood cancers could benefit from a discovery may lead to new treatments to slow or reverse the disease.
Jun 22, 2023
0
9
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with acute myeloid leukemia (AML) and second complete remission (CR2) have significantly improved over time, according to a study published ...
Jun 16, 2023
0
2
Researchers at Children's Hospital of Philadelphia (CHOP) have identified a molecule that plays a role in post-translational modification and activation in myeloid malignancies, making it a potential therapeutic target. The ...
Jun 16, 2023
0
11
